Last reviewed · How we verify
NCT04663958
Predictive Value of Ariscat Index In The Development of Pulmonary Complication After Major Abdominal Cancer Surgery
trial testing Detection / Screening in Postoperative Complications in 410 participants. Completed in 18 August 2021.
18 June 2021
Quick facts
| Lead sponsor | Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 410 |
| Start date | 21 December 2020 |
| Primary completion | 18 June 2021 |
| Estimated completion | 18 August 2021 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Detection / Screening
Conditions studied
- Postoperative Complications — all drugs for Postoperative Complications →
- Cancer — all drugs for Cancer →
- Pulmonary Complication — all drugs for Pulmonary Complication →
- Atelectasis — all drugs for Atelectasis →
Sponsor
Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital
Who can join
18 and older, any sex, with Postoperative Complications or Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The term postoperative pulmonary complication is the development of any complications affecting the respiratory system after anesthetic and surgery procedures. The ARISCAT risk assessment score is a seven-variable regression model that divides patients into low, moderate, and high-risk groups. In this study, the investigators aimed to investigate the effectiveness of the ARISCAT risk scoring index in predicting postoperative pulmonary complication development in patients scheduled for major abdominal cancer surgery.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04663958
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Postoperative Complications
Currently open trials in the same condition.
- NCT07428057 — Postoperative Hypocalcemia After Thyroidectomy · recruiting
- NCT07401173 — DeepComp for Prediction of Gastric Cancer Postoperative Complications (DeepComp-Prospective) · recruiting
- NCT07388108 — Atrial Dyssynchrony to Predict Arrhythmias in the Postoperative Setting of Cardiovascular Surgery. · recruiting
- NCT07375602 — A Multimodal AI Prediction Model for Complications After Transcatheter Closure of Perimembranous VSD in Children · recruiting
- NCT07349719 — Dynamic Compliance-Guided Ventilation in Lumbar Surgery · NA · recruiting
Other Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital trials
Trials by the same sponsor.
- NCT07394816 — Can Ultrasound-Guided Fascial Plane Blocks Reduce Postoperative Pulmonary Complications After Major Abdominal Surgery? · not yet recruiting
- NCT07509697 — Artificial Intelligence-Based Evaluation of Chest X-Rays in Ventilator-Associated Pneumonia · completed
- NCT07440095 — Mortality Predictors in Patients 80+ After Major Abdominal Surgery: Role of Frailty and Physiological Reserve · not yet recruiting
- NCT07392086 — Comparison of FCV and VCV in One-Lung Ventilation · recruiting
- NCT07325617 — Tracking AI/LLM Literacy and Knowledge in Urology Outpatients (TALK-U) · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04663958 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital
- Last refreshed: 18 November 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04663958.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing